Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

SYNTHETIC PEPTIDES WHICH INDUCE CELLULAR IMMUNITY TO THE AIDS VIRUS AND AIDS VIRAL PROTEINS

  • Read more about SYNTHETIC PEPTIDES WHICH INDUCE CELLULAR IMMUNITY TO THE AIDS VIRUS AND AIDS VIRAL PROTEINS
US Patent 5,081,226
Filed on 1990-02-28

PEPTIDES STIMULATING CYTOTOXIC T CELLS IMMUNE TO HIV RT

  • Read more about PEPTIDES STIMULATING CYTOTOXIC T CELLS IMMUNE TO HIV RT
US Patent 5,336,758
Filed on 1990-03-09

MATRIX METALLOPROTEINASE PEPTIDES: ROLE IN DIAGNOSIS AND THERAPY

  • Read more about MATRIX METALLOPROTEINASE PEPTIDES: ROLE IN DIAGNOSIS AND THERAPY
US Patent 5,280,106
Filed on 1990-02-26

ENDOGENOUS SURAMIN-INDUCED, SULFATED GLYCOSAMINO-GLYCANS AS ANTI- CANCER AGENTS IN HUMANS

  • Read more about ENDOGENOUS SURAMIN-INDUCED, SULFATED GLYCOSAMINO-GLYCANS AS ANTI- CANCER AGENTS IN HUMANS
US Application 07/488,105
Filed on 1990-03-05

THE USE OF XYLAN POLYHYDROGENSULFATES FOR THE THERAPY OF DISORDERS BASED ON CELL PROLIFERATION

  • Read more about THE USE OF XYLAN POLYHYDROGENSULFATES FOR THE THERAPY OF DISORDERS BASED ON CELL PROLIFERATION
US Application 07/487,881
Filed on 1990-03-06

IMMORTALIZED HUMAN BRONCHIAL EPITHELIAL CELL LINE

  • Read more about IMMORTALIZED HUMAN BRONCHIAL EPITHELIAL CELL LINE
US Application 07/487,626
Filed on 1990-03-02

METHOD FOR FACILITATING ENGRAFTMENT OF ANALLOGENEIC TISSUE OR ORGAN USING INTERLEUKIN 2

  • Read more about METHOD FOR FACILITATING ENGRAFTMENT OF ANALLOGENEIC TISSUE OR ORGAN USING INTERLEUKIN 2
US Application 07/485,879
Filed on 1990-02-27

Method for the Fluorescent Detection of a DNA Sequence in Real Time

  • Read more about Method for the Fluorescent Detection of a DNA Sequence in Real Time
US Application 07/484,573
Filed on 1990-02-26

USE OF SURAMIN TO TREAT RHEUMATOLOGIC DISEASES

  • Read more about USE OF SURAMIN TO TREAT RHEUMATOLOGIC DISEASES
US Patent 5,158,940
Filed on 1990-02-14

ANTI-VIRAL COMPOUNDS AND THEIR USES

  • Read more about ANTI-VIRAL COMPOUNDS AND THEIR USES
US Application 07/477,406
Filed on 1990-02-09

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1642
  • Page 1643
  • Page 1644
  • Page 1645
  • Page 1646
  • Page 1647
  • Page 1648
  • Page 1649
  • Page 1650
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health